Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | MKNK1 | Q9BUB5 | 5/20 | 0.32 |
| ▸ | MKNK2 | Q9HBH9 | 5/20 | 0.32 |
| ▸ | NNMT | P40261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.32 |
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.31 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.31 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.31 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.31 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.31 |
| ▸ | CDC7 | O00311 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11163287 | 0.84 | PARP1 (0.38) | PARP10PARP15PARP14CDC7PLK4 | |
| SCHEMBL7666295 | 0.72 | OPRD1 (0.38) | OPRD1MKNK1MKNK2SMN1; SMN2PARP10 | |
| SCHEMBL3963134 | 0.66 | MKNK2 (0.47) | CA2CA12CA1CA9CA14 | |
| Terephthalamide SCHEMBL693310 | 0.65 | CA2 (0.65) | CA2CA12CA1CA9CA14 | |
| SCHEMBL11212615 | 0.63 | SMN1; SMN2 (0.33) | CA2MKNK1MKNK2NNMTSMN1; SMN2 | |
| SCHEMBL7664520 | 0.63 | PLA2G10 (0.50) | MKNK1MKNK2NNMTSMN1; SMN2PARP10 | |
| SCHEMBL27268295 | 0.63 | HDAC3 (0.41) | SMN1; SMN2ALDH1A1KMT2APOLBMAPT | |
| SCHEMBL6328868 | 0.63 | TSHR (0.52) | CA2CA12CA1CA9CA14 | |
| SCHEMBL7433283 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL9231395 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | BASF SE (DE) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | STS, NAPA, NAAA | CA2 1016/4885CA12 1436/4885CA1 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.